Nobilis Gumboro 228E

Gumboro 228E: power plus balance

In vaccination against Gumboro Disease, there are two conventional choices:

1. Intermediate vaccines have few side effects, but limited efficacy against vvIBD in the field or in situations of high infectious pressure.
2. Hot vaccines have a powerful and aggressive action, but can damage the bursa, impairing the immune response and response to other vaccinations.

Gumboro 228E gives you a more balanced option -an Intermediate Plus vaccine combining the power of a hot vaccine with the safety of an intermediate.

Unrivalled protection, without immuno-suppression.

Gumboro 228E has the power to break through higher titres of maternally derived antibodies (MDA) than intermediate vaccines - but without immuno-suppression, as demonstrated by:

• Extensive laboratory trials
• Pathological examination of the bursa
• Performance in Gumboro outbreaks, world-wide.